Your browser doesn't support javascript.
loading
Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial.
Kraeber-Bodere, Françoise; Pallardy, Amandine; Maisonneuve, Hervé; Campion, Loïc; Moreau, Anne; Soubeyran, Isabelle; Le Gouill, Steven; Tournilhac, Olivier; Daguindau, Etienne; Jardel, Henry; Morineau, Nadine; Bouabdallah, Krimo; Gyan, Emmanuel; Moles, Marie-Pierre; Gressin, Remy; Berthou, Christian; Sadot, Sophie; Moreau, Philippe; Deau, Bénédicte; Bodet-Milin, Caroline; Cazeau, Anne-Laure; Garin, Etienne; Salaun, Pierre-Yves; Vuillez, Jean-Philippe; Gouilleux-Gruart, Valérie; Barbet, Jacques; Wegener, William A; Goldenberg, David M; Lamy, Thierry; Soubeyran, Pierre.
Afiliación
  • Kraeber-Bodere F; University Hospital, Nantes, France; Institut de Cancérologie de l'Ouest Cancer Center, Saint-Herblain, France. Electronic address: francoise.bodere@chu-nantes.fr.
  • Pallardy A; University Hospital, Nantes, France.
  • Maisonneuve H; Haematology Department, Hospital, La Roche sur Yon, France.
  • Campion L; Institut de Cancérologie de l'Ouest Cancer Center, Saint-Herblain, France.
  • Moreau A; University Hospital, Nantes, France.
  • Soubeyran I; Institut Bergonié, Cancer Centre, and University of Bordeaux, Bordeaux, France.
  • Le Gouill S; University Hospital, Nantes, France.
  • Tournilhac O; University Hospital, Clermont-Ferrand, France.
  • Daguindau E; Jean Minjoz Hospital, Besançon, France.
  • Jardel H; Centre Hospitalier Bretagne-Atlantique, Vannes, France.
  • Morineau N; Catherine de Sienne Center, Nantes, France.
  • Bouabdallah K; University Hospital Haut-Leveque, Bordeaux, France.
  • Gyan E; Hematology and Cell Therapy Department, Clinical Investigation Center INSERM U1415, GICC UMR CNRS 7292, University Hospital, Tours, France.
  • Moles MP; University Hospital, Angers, France.
  • Gressin R; University Hospital, Grenoble, France.
  • Berthou C; University Hospital, Brest, France.
  • Sadot S; Institut de Cancérologie de l'Ouest Cancer Center, Saint-Herblain, France.
  • Moreau P; Hôpital du Scorff, Lorient, France.
  • Deau B; Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Bodet-Milin C; University Hospital, Nantes, France.
  • Cazeau AL; Institut Bergonié, Cancer Centre, and University of Bordeaux, Bordeaux, France.
  • Garin E; Eugène Marquis Cancer Center, Rennes, France.
  • Salaun PY; University Hospital, Brest, France.
  • Vuillez JP; University Hospital, Grenoble, France.
  • Gouilleux-Gruart V; Hematology and Cell Therapy Department, Clinical Investigation Center INSERM U1415, GICC UMR CNRS 7292, University Hospital, Tours, France.
  • Barbet J; Groupement d'Intêret Publique Arronax, Arronax, Saint-Herblain, France.
  • Wegener WA; Clinical Research, Immunomedics, Morris Plains, NJ, USA.
  • Goldenberg DM; Clinical Research, Immunomedics, Morris Plains, NJ, USA.
  • Lamy T; University Hospital, Rennes, France.
  • Soubeyran P; Institut Bergonié, Cancer Centre, and University of Bordeaux, Bordeaux, France.
Lancet Haematol ; 4(1): e35-e45, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27964867
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Radioisótopos de Itrio / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Radioinmunoterapia / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Radioisótopos de Itrio / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Radioinmunoterapia / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Año: 2017 Tipo del documento: Article